Replies to post #132326 on Anavex Life Sciences Corp (AVXL)

[mapman1010]

Thank You

[Investor2014]

Why would A2-73 not simply fall under this existing 2014 (draft) guidance and one of the expedite approval paths defined in it?

https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf

What else specifically might we be waiting for?